Dean’s personal mission is to fulfill the potential of technology to ensure cancer patients receive the best treatment possible. This was born out of firsthand experience facing the pain points and gaps of cancer-related diagnosis and treatment.
Dean is the CEO and co-founder of Imagene, an emerging leader in the field of precision medicine for cancer revolutionizing biomarker real-time detection to optimize treatment decisions.
Imagene AI in Endpoints